191 years old, still crushing it

Age is just a number when you have these metrics ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

BROUGHT TO YOU BY MANWARD PRESS Dealmaker's Diary: This 191-Year-Old Company Is Beating 90% of the Market SPONSORED Elon set to launch his biggest project yet By as soon as August 8… Elon could roll out​ ​​what one ex-Wall Street insider is calling​ “Project Infinity.”  An AI project that Elon himself says “Will be the biggest project of any kind.”  Not only could it be the biggest, but it could also create the most wealth of any project ever… So much that Morgan Stanley says it could be worth $30 trillion. Click here to discover ​a "backdoor" way for everyday Americans to profit from this "Project."   Alpesh Patel Quantitative Investing Specialist A 191-year-old company is quietly crushing 90% of the market. No flashy marketing. No breathless hype. Just phenomenal numbers that most investors completely ignore. This healthcare infrastructure giant has been around since 1833. It survived the Civil War, two World Wars, the Great Depression, and every market crash since. Now it's using cutting-edge AI to revolutionize healthcare delivery - and the results are staggering. SPONSORED Unlock the Ultimate Gold Play: $20 for a 1-Oz. Stake in Gold! Gold has already soared past $2,500 an ounce. But with this 'backdoor' strategy, you can gain exposure to over an ounce for just $20. As the Fed cuts rates, the stage is set for a major gold boom. Don't miss out—click here for urgent details on the #1 gold play of the year!   The metrics that caught my eye... Top cash returns on invested capital Sortino ratio near 1.0 (a rare one) Volatility of less than 10%. While everyone argues about which startup will "disrupt healthcare," this proven giant is already doing it with... AI-powered disease forecasting Robotics automation in distribution Microsoft Azure integration for oncology insights. Click here or on the image below to see why age isn't slowing this giant down. Happy hunting, Alpesh WATCH THE VIDEO (WITH TRANSCRIPT) SPONSORED He Picked Apple at $1... and Netflix at $2... Now He's Betting Big on This $5 AI Stock CLICK HERE TO FIND OUT WHAT IT IS   Want more content like this? YES NO

Alpesh Patel Alpesh Patel is an award-winning hedge fund and private equity fund manager, international bestselling author, and entrepreneur. He is the founder and CEO of Praefinium Partners, a Financial Times top FTSE 100 forecaster, and a senior Dealmaker in the U.K.'s Department for International Trade. As a recognized authority on fintech, online trading and venture capital, his past and current client list includes American Express, Merrill Lynch HSBC, Charles Schwab, Goldman Sachs, Barclays... and more.

You are receiving this email because you subscribed to Total Wealth. To unsubscribe from Total Wealth, click here. Need help with your account? Click here. Have a question or comment for the editor? Click here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Manward Press | Attn: Member Services | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 800.682.5210 | International: +1.443.353.4263 Website | Privacy Policy Keep the emails you value from falling into your spam folder. Whitelist Total Wealth. © 2025 Manward Press, LLC | All Rights Reserved

Nothing published by Manward Press, LLC should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by Manward Press, LLC should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Manward Press, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.